# C-Cog in Early Course Schizophrenia Study

> **NCT05662306** · PHASE4 · TERMINATED · sponsor: **University of Miami** · enrollment: 1 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole Lauroxil
- **BEHAVIORAL:** Computerized cognitive and functional skills training

## Key facts

- **NCT ID:** NCT05662306
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-23
- **Primary completion:** 2025-03-03
- **Final completion:** 2025-03-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Recruitment issues
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662306, "C-Cog in Early Course Schizophrenia Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05662306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*